The fact that covering GLP-1s under Medicare Part D for authorized uses is already making a mark on total Part D program spending could be a sign of even higher spending to come as Part D plans are now able to cover Wegovy for its heart health benefits, as other uses for GLP-1s are approved, and as policymakers consider legislation that would authorize Medicare to cover obesity drugs
PRP uses the patients own blood to stimulate hair follicles and encourage natural hair regrowth
In Phase 2 clinical trial (NEJM, 2023), participants on 12 mg dose lost up to 24% body weight over 48 weeks the best result among all weight loss medications
Step 1: identify your primary goal What matters most to you
No adverse effects were reported
Ayoub, M., Faris, C., Juranovic, T., Chela, H